Literature DB >> 35250117

Discerning in vitro pharmacodynamics from OD measurements: A model-based approach.

Iordanis Kesisoglou1, Vincent H Tam2,1, Andrew P Tomaras3, Michael Nikolaou1.   

Abstract

Time-kill experiments can discern the pharmacodynamics of infectious bacteria exposed to antibiotics in vitro, and thus help guide the design of effective therapies for challenging clinical infections. This task is resource-limited, therefore typically bypassed in favor of empirical shortcuts. The resource limitation could be addressed by continuously assessing the size of a bacterial population under antibiotic exposure using optical density measurements. However, such measurements count both live and dead cells and are therefore unsuitable for declining populations of live cells. To fill this void, we develop here a model-based method that infers the count of live cells in a bacterial population exposed to antibiotics from continuous optical-density measurements of both live and dead cells combined. The method makes no assumptions about the underlying mechanisms that confer resistance and is widely applicable. Use of the method is demonstrated by an experimental study on Acinetobacter baumannii exposed to levofloxacin.

Entities:  

Keywords:  Combination therapy; Mathematical modeling; Multi-drug resistant bacteria; Pharmacodynamics

Year:  2021        PMID: 35250117      PMCID: PMC8896896          DOI: 10.1016/j.compchemeng.2021.107617

Source DB:  PubMed          Journal:  Comput Chem Eng        ISSN: 0098-1354            Impact factor:   3.845


  39 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  Statistical evaluation of mathematical models for microbial growth.

Authors:  S López; M Prieto; J Dijkstra; M S Dhanoa; J France
Journal:  Int J Food Microbiol       Date:  2004-11-15       Impact factor: 5.277

Review 3.  A review of conventional detection and enumeration methods for pathogenic bacteria in food.

Authors:  Kiev S Gracias; John L McKillip
Journal:  Can J Microbiol       Date:  2004-11       Impact factor: 2.419

Review 4.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

Authors:  Ae Jung Huh; Young Jik Kwon
Journal:  J Control Release       Date:  2011-07-06       Impact factor: 9.776

5.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 6.  Platforms for antibiotic discovery.

Authors:  Kim Lewis
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

Review 7.  Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.

Authors:  Kieron M G O'Connell; James T Hodgkinson; Hannah F Sore; Martin Welch; George P C Salmond; David R Spring
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-05       Impact factor: 15.336

8.  An optimized SYBR Green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi.

Authors:  Jie Feng; Ting Wang; Shuo Zhang; Wanliang Shi; Ying Zhang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

9.  A rapid and low-cost estimation of bacteria counts in solution using fluorescence spectroscopy.

Authors:  Rachel Guo; Cushla McGoverin; Simon Swift; Frederique Vanholsbeeck
Journal:  Anal Bioanal Chem       Date:  2017-04-07       Impact factor: 4.142

Review 10.  The challenge of emerging and re-emerging infectious diseases.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.